Dual targeting of vascular endothelial growth factor (VEGF) with sorafenib and bevacizumab: Clinical and translational results von Azad, N. S., Annunziata, C., Barrett, T., Chen, C., Steinberg, S., Kwitkowski, V. E., McNally, D., Kotz, H., Minasian, L., Kohn, E. C.

Volltext

PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) von Basch, E, Reeve, B, Cleeland, C, Sloan, J, Schrag, D, Atkinson, TM, Mendoza, T, Hay, J, Abernethy, A, Minasian, L, Kwitkowski, V, Trentacosti, AM, Burke, L, Sit, L, Bruner, D

Volltext

3 Overview of proteomics with emphasis on diagnosis and monitoring von Kohn, E.C., Posadas, E.M., Espina, V., Kwitkowski, V., Davidson, B., Petricoin, E.F., Liotta, L.

Volltext

Increased efficacy and toxicity with combination anti-VEGF therapy using sorafenib and bevacizumab von Azad, N. S., Posadas, E. M., Kwitkowski, V. E., Annunziata, C. M., Barrett, T., Premkumar, A., Kotz, H. L., Sarosy, G. A., Minasian, L. M., Kohn, E. C.

Volltext

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma von Lee, Hyon-Zu, Kwitkowski, Virginia E, Del Valle, Pedro L, Ricci, M Stacey, Saber, Haleh, Habtemariam, Bahru A, Bullock, Julie, Bloomquist, Erik, Li Shen, Yuan, Chen, Xiao-Hong, Brown, Janice, Mehrotra, Nitin, Dorff, Sarah, Charlab, Rosane, Kane, Robert C, Kaminskas, Edvardas, Justice, Robert, Farrell, Ann T, Pazdur, Richard

Volltext

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma von Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Mitchell, Shan Sun, Sridhara, Rajeshwari, Pazdur, Richard

Volltext

Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentation von Kanapuru, Bindu, Singh, Harpreet, Kwitkowski, Virginia, Blumenthal, Gideon, Farrell, Ann T., Pazdur, Richard

Volltext

U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia von LEE, Hyon-Zu, MILLER, Barry W, KO, Chia-Wen, LEI NIE, SHAPIRO, Marjorie, TOLNAY, Mate, KANE, Robert C, KAMINSKAS, Edvardas, JUSTICE, Robert, FARRELL, Ann T, PAZDUR, Richard, KWITKOWSKI, Virginia E, RICCI, Stacey, DELVALLE, Pedro, SABER, Haleh, GRILLO, Joseph, BULLOCK, Julie, FLORIAN, Jeffry, MEHROTRA, Nitin

Volltext

Large-Scale Screening for Targeted Knockouts in the Caenorhabditis elegans Genome

Volltext

A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer von Posadas, Edwin M., Liel, Meghan S., Kwitkowski, Virginia, Minasian, Lori, Godwin, Andrew K., Hussain, Mahrukh M., Espina, Virginia, Wood, Bradford J., Steinberg, Seth M., Kohn, Elise C.

Volltext

A prospective analysis of imatinib‐induced c‐kit modulation in ovarian cancer von Posadas, Edwin M., Kwitkowski, Virginia, Kotz, Herbert L., Espina, Virginia, Minasian, Lori, Tchabo, Nana, Premkumar, Ahalya, Hussain, Mahrukh M., Chang, Richard, Steinberg, Seth M., Kohn, Elise C.

Volltext

Design, Synthesis, and In Vitro Antiproliferative Screening of New Hydrazone Derivatives Containing cis-(4-Chlorostyryl) Amide Moiety von Al-Warhi, Tarfah, Alqahtani, Leena S., Abualnaja, Matokah, Beigh, Saba, Abu Ali, Ola A., Elsaid, Fahmy G., Shati, Ali A., Saleem, Rasha Mohammed, Maghrabi, Ali Hassan Ahmed, Alharthi, Amani Abdulrahman, Alyamani, Amal, Fayad, Eman, Abu Almaaty, Ali H., Zaki, Islam, Hamouda, Shaimaa

Volltext

Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer von Tsimberidou, Apostolia-Maria, Shaw, Jamie V, Juric, Dejan, Verschraegen, Claire, Weise, Amy M, Sarantopoulos, John, Lopes, Gilberto, Nemunaitis, John, Mita, Monica, Park, Haeseong, Ellers-Lenz, Barbara, Tian, Hui, Xiong, Wenyuan, Kaleta, Remigiusz, Kurzrock, Razelle

Volltext

Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period von Lee, M. K., Basch, E., Mitchell, S. A., Minasian, L. M., Langlais, B. T., Thanarajasingam, G., Ginos, B. F., Rogak, L. J., Mendoza, T. R., Bennett, A. V., Schrag, D., Mazza, G. L., Dueck, A. C.

Volltext

Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer von Naumann, F V, Sweep, F C G J, Adema, G J, Peeters, W J M, Martens, J W M, Bussink, J, Span, P N

Volltext

Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases von Fares, Jawad, Petrosyan, Edgar, Kanojia, Deepak, Dmello, Crismita, Cordero, Alex, Duffy, Joseph T, Yeeravalli, Ragini, Sahani, Mayurbhai H, Zhang, Peng, Rashidi, Aida, Arrieta, Victor A, Ulasov, Ilya, Ahmed, Atique U, Miska, Jason, Balyasnikova, Irina V, James, C David, Sonabend, Adam M, Heimberger, Amy B, Lesniak, Maciej S

Volltext

Accelerating discoveries in medicine using distributed vector representations of words von Berto, Matheus V.V., Freitas, Breno L., Scarton, Carolina, Machado-Neto, João A., Almeida, Tiago A.

Volltext

Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 von Regnault, Antoine, Pompilus, Farrah, Ciesluk, Anna, Mazerolle, Flora, Bejar, Rafael, Fram, Robert J., Faller, Douglas V., Marquis, Patrick, Bell, Jill A.

Volltext

Rapalogs in cancer prevention: Anti-aging or anticancer? von Blagosklonny, Mikhail V.

Volltext

Design and development of novel inhibitors of aldo-ketoreductase 1C1 as potential lead molecules in treatment of breast cancer von Verma, Priyanka, Hassan, Md. Imtaiyaz, Singh, Archana, Singh, Indrakant K.

Volltext